Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome
ABSTRACT Obstructive sleep apnea (OSA) is a common disorder characterized by episodic obstruction to breathing due to upper airway collapse during sleep. Because of the episodic airway obstruction, intermittently low O2 (hypoxia) and high CO2 (hypercapnia) ensue. OSA has been associated with adverse...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c01326f5b4b0417ba6d9d3532c83605c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c01326f5b4b0417ba6d9d3532c83605c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c01326f5b4b0417ba6d9d3532c83605c2021-12-02T18:15:44ZIntermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome10.1128/mSystems.00020-182379-5077https://doaj.org/article/c01326f5b4b0417ba6d9d3532c83605c2018-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00020-18https://doaj.org/toc/2379-5077ABSTRACT Obstructive sleep apnea (OSA) is a common disorder characterized by episodic obstruction to breathing due to upper airway collapse during sleep. Because of the episodic airway obstruction, intermittently low O2 (hypoxia) and high CO2 (hypercapnia) ensue. OSA has been associated with adverse cardiovascular and metabolic outcomes, although data regarding potential causal pathways are still evolving. As changes in inspired O2 and CO2 can affect the ecology of the gut microbiota and the microbiota has been shown to contribute to various cardiometabolic disorders, we hypothesized that OSA alters the gut ecosystem, which, in turn, exacerbates the downstream physiological consequences. Here, we model human OSA and its cardiovascular consequence using Ldlr−/− mice fed a high-fat diet and exposed to intermittent hypoxia and hypercapnia (IHH). The gut microbiome and metabolome were characterized longitudinally (using 16S rRNA amplicon sequencing and untargeted liquid chromatography-tandem mass spectrometry [LC-MS/MS]) and seen to covary during IHH. Joint analysis of microbiome and metabolome data revealed marked compositional changes in both microbial (>10%, most remarkably in Clostridia) and molecular (>22%) species in the gut. Moreover, molecules that altered in abundance included microbe-dependent bile acids, enterolignans, and fatty acids, highlighting the impact of IHH on host-commensal organism cometabolism in the gut. Thus, we present the first evidence that IHH perturbs the gut microbiome functionally, setting the stage for understanding its involvement in cardiometabolic disorders. IMPORTANCE Intestinal dysbiosis mediates various cardiovascular diseases comorbid with OSA. To understand the role of dysbiosis in cardiovascular and metabolic disease caused by OSA, we systematically study the effect of intermittent hypoxic/hypercapnic stress (IHH, mimicking OSA) on gut microbes in an animal model. We take advantage of a longitudinal study design and paired omics to investigate the microbial and molecular dynamics in the gut to ascertain the contribution of microbes on intestinal metabolism in IHH. We observe microbe-dependent changes in the gut metabolome that will guide future research on unrecognized mechanistic links between gut microbes and comorbidities of OSA. Additionally, we highlight novel and noninvasive biomarkers for OSA-linked cardiovascular and metabolic disorders.Anupriya TripathiAlexey V. MelnikJin XueOrit PoulsenMichael J. MeehanGregory HumphreyLingjing JiangGail AckermannDaniel McDonaldDan ZhouRob KnightPieter C. DorresteinGabriel G. HaddadAmerican Society for Microbiologyarticlecardiovascularmetabolismmicrobiomesleep apneaMicrobiologyQR1-502ENmSystems, Vol 3, Iss 3 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
cardiovascular metabolism microbiome sleep apnea Microbiology QR1-502 |
spellingShingle |
cardiovascular metabolism microbiome sleep apnea Microbiology QR1-502 Anupriya Tripathi Alexey V. Melnik Jin Xue Orit Poulsen Michael J. Meehan Gregory Humphrey Lingjing Jiang Gail Ackermann Daniel McDonald Dan Zhou Rob Knight Pieter C. Dorrestein Gabriel G. Haddad Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome |
description |
ABSTRACT Obstructive sleep apnea (OSA) is a common disorder characterized by episodic obstruction to breathing due to upper airway collapse during sleep. Because of the episodic airway obstruction, intermittently low O2 (hypoxia) and high CO2 (hypercapnia) ensue. OSA has been associated with adverse cardiovascular and metabolic outcomes, although data regarding potential causal pathways are still evolving. As changes in inspired O2 and CO2 can affect the ecology of the gut microbiota and the microbiota has been shown to contribute to various cardiometabolic disorders, we hypothesized that OSA alters the gut ecosystem, which, in turn, exacerbates the downstream physiological consequences. Here, we model human OSA and its cardiovascular consequence using Ldlr−/− mice fed a high-fat diet and exposed to intermittent hypoxia and hypercapnia (IHH). The gut microbiome and metabolome were characterized longitudinally (using 16S rRNA amplicon sequencing and untargeted liquid chromatography-tandem mass spectrometry [LC-MS/MS]) and seen to covary during IHH. Joint analysis of microbiome and metabolome data revealed marked compositional changes in both microbial (>10%, most remarkably in Clostridia) and molecular (>22%) species in the gut. Moreover, molecules that altered in abundance included microbe-dependent bile acids, enterolignans, and fatty acids, highlighting the impact of IHH on host-commensal organism cometabolism in the gut. Thus, we present the first evidence that IHH perturbs the gut microbiome functionally, setting the stage for understanding its involvement in cardiometabolic disorders. IMPORTANCE Intestinal dysbiosis mediates various cardiovascular diseases comorbid with OSA. To understand the role of dysbiosis in cardiovascular and metabolic disease caused by OSA, we systematically study the effect of intermittent hypoxic/hypercapnic stress (IHH, mimicking OSA) on gut microbes in an animal model. We take advantage of a longitudinal study design and paired omics to investigate the microbial and molecular dynamics in the gut to ascertain the contribution of microbes on intestinal metabolism in IHH. We observe microbe-dependent changes in the gut metabolome that will guide future research on unrecognized mechanistic links between gut microbes and comorbidities of OSA. Additionally, we highlight novel and noninvasive biomarkers for OSA-linked cardiovascular and metabolic disorders. |
format |
article |
author |
Anupriya Tripathi Alexey V. Melnik Jin Xue Orit Poulsen Michael J. Meehan Gregory Humphrey Lingjing Jiang Gail Ackermann Daniel McDonald Dan Zhou Rob Knight Pieter C. Dorrestein Gabriel G. Haddad |
author_facet |
Anupriya Tripathi Alexey V. Melnik Jin Xue Orit Poulsen Michael J. Meehan Gregory Humphrey Lingjing Jiang Gail Ackermann Daniel McDonald Dan Zhou Rob Knight Pieter C. Dorrestein Gabriel G. Haddad |
author_sort |
Anupriya Tripathi |
title |
Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome |
title_short |
Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome |
title_full |
Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome |
title_fullStr |
Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome |
title_full_unstemmed |
Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome |
title_sort |
intermittent hypoxia and hypercapnia, a hallmark of obstructive sleep apnea, alters the gut microbiome and metabolome |
publisher |
American Society for Microbiology |
publishDate |
2018 |
url |
https://doaj.org/article/c01326f5b4b0417ba6d9d3532c83605c |
work_keys_str_mv |
AT anupriyatripathi intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT alexeyvmelnik intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT jinxue intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT oritpoulsen intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT michaeljmeehan intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT gregoryhumphrey intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT lingjingjiang intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT gailackermann intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT danielmcdonald intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT danzhou intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT robknight intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT pietercdorrestein intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome AT gabrielghaddad intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome |
_version_ |
1718378358485549056 |